Correct Answer: A. <1
Anti-Müllerian hormone (AMH) is a dimeric glycoprotein produced by granulosa cells of preantral and small antral follicles in the ovary. It serves as the most reliable marker of ovarian reserve—the number and quality of remaining oocytes. In low ovarian reserve (diminished ovarian reserve, DOR), the number of small growing follicles is reduced, leading to decreased AMH production. The discriminating fact: AMH levels <1 ng/mL (or <0.7 IU/L) indicate severely diminished ovarian reserve and predict poor response to ovarian stimulation in assisted reproductive technology (ART). This threshold is widely accepted in Indian fertility guidelines and international consensus (ASRM, ESHRE). AMH is superior to day-3 FSH and antral follicle count (AFC) because it remains stable throughout the menstrual cycle, is not affected by hormonal contraceptives, and correlates directly with the primordial and primary follicle pool. In clinical practice, AMH <1 ng/mL warrants counseling about reduced fertility potential, poor ovarian response, and higher cycle cancellation rates in IVF. The inverse relationship between AMH and age is well-established: as women age and ovarian reserve declines, AMH drops exponentially.
Why the other options are wrong
B. >10 IU/L — This is wrong because AMH >10 ng/mL (or >10 IU/L) indicates high ovarian reserve or polycystic ovary syndrome (PCOS), not low ovarian reserve. This level reflects abundant small follicles and excellent ovarian response. The trap: students may confuse high AMH with poor reserve if they misremember the inverse relationship between AMH and age. C. >7 — This is wrong because AMH >7 ng/mL represents normal to high ovarian reserve, not low reserve. This threshold is typically seen in younger women with good fertility potential. The NBE trap: students may select this thinking 'higher is better' without recalling that low ovarian reserve requires low AMH values, not high ones. D. 1-4 — This is wrong because AMH 1–4 ng/mL represents normal to borderline ovarian reserve, not low reserve. While this range may warrant monitoring in older women, it does not meet the diagnostic threshold for diminished ovarian reserve. Low reserve specifically requires AMH <1 ng/mL, making this a distractor for students who confuse borderline with low.
High-Yield Facts
- AMH <1 ng/mL = severely diminished ovarian reserve; predicts poor ovarian response in ART and high cycle cancellation risk.
- AMH 1–4 ng/mL = normal to borderline reserve; acceptable for natural conception but may require monitoring in women >35 years.
- AMH >10 ng/mL = high ovarian reserve or PCOS; risk of ovarian hyperstimulation syndrome (OHSS) in IVF cycles.
- AMH is cycle-independent and unaffected by hormonal contraceptives, making it superior to day-3 FSH for ovarian reserve assessment.
- AMH declines exponentially with age; by age 40, median AMH is ~1 ng/mL; by age 45, <0.5 ng/mL in most women.
Mnemonics
AMH & Ovarian Reserve (Direct Inverse) Low AMH = Low Reserve | High AMH = High Reserve. Think: fewer follicles → less AMH production. Use this when comparing AMH values to ovarian reserve status in any fertility case. AMH Cutoff Memory (ng/mL) <1 = Poor | 1–4 = Normal | >10 = High/PCOS. Memorize these three buckets for rapid classification in clinical exams and fertility counseling.
NBE Trap
NBE pairs "low ovarian reserve" with AMH cutoffs to test whether students confuse the inverse relationship: students who think "higher AMH = better reserve" may incorrectly select >7 or >10, missing that diminished reserve requires AMH <1 ng/mL.
Clinical Pearl
In Indian fertility clinics, AMH <1 ng/mL is the red flag that triggers counseling about reduced fertility, need for expedited ART, and consideration of donor oocytes. A 42-year-old woman with AMH 0.6 ng/mL and regular cycles has poor ovarian reserve despite normal FSH—this is why AMH is now the first-line test in Indian fertility centers.
_Reference: DC Dutta's Textbook of Obstetrics (Assisted Reproductive Technology chapter); ASRM/ESHRE consensus on ovarian reserve testing; Harrison Ch. 346 (Infertility and Reproductive Endocrinology)_